Aktienanalyse zu Akso Health Group (AHG)AHGAkso Health Group

Akso Health Group is a holding company mainly engaged in marketing promotion services and sales of medical devices. The marketing promotion services business is principally engaged in the provision of marketing promotion services to car insurance broker industry. The sales of medical devices business is mainly engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscope. The Company also provides radiotherapy (RT), personalized consultation, conventional treatment planning, and other related services for a wide variety of cancer therapy treatments, as well as online healthcare services, including health consultancy services and online sales of medicines and health products through the online health product marketplace. It operates in the Technology sector (BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED industry).

Akso Health Group (AHG) is a good buy right now due to its recent price surge of 9.65% yesterday and an impressive 48.95% increase over the last 20 days. The current RSI of 78.524 indicates strong momentum, although it is approaching overbought territory. The stock's projected final change of +161.29% based on historical patterns suggests substantial upside potential. However, the main risk is its negative P/E ratio of -6.036, indicating potential underlying issues with profitability.